EV/EBITDA
-0.78
+0.11+12.36%
102 min ago
Summary
- As of February 7, 2025, TCRX EV/EBITDA is -0.78, with a rise of +0.11 (+12.36%) during the most recent trading day.
- Over the past year, TCRX EV/EBITDA has increased by +2.17 (+73.56%).
- TCRX EV/EBITDA is now -141.27% below its all-time high of 1.89.
Performance
TCRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TCRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +12.4% | -11.8% | -8.0% |
| 1 m1 month | +35.0% | -35.1% | -26.1% |
| 3 m3 months | +69.2% | -69.1% | -61.6% |
| 6 m6 months | +52.1% | -48.6% | -62.5% |
| ytdytd | +38.1% | -37.9% | -28.5% |
| 1 y1 year | +73.6% | -66.0% | -62.4% |
| 5 y5 years | - | - | - |
TCRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -1.20 | +35.0% | |
| 3 m | 3-month | -0.78 | at high | -2.58 | +69.8% |
| 6 m | 6-month | -0.78 | at high | -2.63 | +70.3% |
| 1 y | 1-year | -0.78 | at high | -5.06 | +84.6% |
| 3 y | 3-year | 1.89 | -141.3% | -5.06 | +84.6% |
| 5 y | 5-year | 1.89 | -141.3% | -7.05 | +88.9% |
| alltime | all time | 1.89 | -141.3% | -7.05 | +88.9% |
TScan Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.78(-38.1%) |
| 2024 | -1.26(-59.5%) |
| Date | Value |
|---|---|
| 2023 | -3.11(+3355.6%) |
| 2022 | -0.09(-108.6%) |
| 2021 | 1.05 |
FAQ
- What is TScan Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TScan Therapeutics?
- What is TCRX EV/EBITDA year-to-date change?
- What is TScan Therapeutics EV/EBITDA year-on-year change?
What is TScan Therapeutics EV/EBITDA?
The current EV/EBITDA of TCRX is -0.78
What is the all time high EV/EBITDA for TScan Therapeutics?
TScan Therapeutics all-time high EV/EBITDA is 1.89
What is TCRX EV/EBITDA year-to-date change?
TScan Therapeutics EV/EBITDA has changed by +0.48 (+38.10%) since the beginning of the year
What is TScan Therapeutics EV/EBITDA year-on-year change?
Over the past year, TCRX EV/EBITDA has changed by +2.17 (+73.56%)